"European Medicines Agency to Approve COVID-19 Vaccine on the 23rd"

[Image source=Yonhap News]

[Asia Economy Reporter Buaeri] The European Medicines Agency (EMA) is reported to make a positive decision on the first COVID-19 vaccine on the 23rd.

According to the German daily Bild and others, the EMA is reviewing the vaccine developed by the American pharmaceutical company Pfizer and the German company BioNTech, and plans to complete the review by the 23rd.

Earlier, the EMA stated that it would decide on the approval of the Pfizer-BioNTech vaccine, for which an emergency use authorization application was recently submitted, by no later than the 29th.

The EMA is the agency responsible for the evaluation and approval of medicines and vaccines within the European Union (EU), and it also handles the approval process for COVID-19 vaccines. When the EMA issues recommendations on new medicines, the EU Commission, which holds the final decision-making authority, follows the EMA's advice.

Accordingly, there is a prospect that the vaccination campaign in Germany could begin on the 26th.

This content was produced with the assistance of AI translation services.